[
  {
    "ts": "2025-12-10T00:11:27+00:00",
    "headline": "Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally",
    "summary": "Johnson & Johnson (JNJ) has quietly ground higher, with the stock up roughly 7% over the past month and nearly 14% in the past 3 months, drawing fresh attention from income focused investors. See our latest analysis for Johnson & Johnson. Zooming out, that steady climb sits on top of a powerful backdrop, with a roughly 39% year to date share price return and a three year total shareholder return above 22% suggesting momentum is still firmly building as investors reassess Johnson & Johnson’s...",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "032baba9-f9f0-3958-912d-bf17b1929a9b",
      "content": {
        "id": "032baba9-f9f0-3958-912d-bf17b1929a9b",
        "contentType": "STORY",
        "title": "Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally",
        "description": "",
        "summary": "Johnson & Johnson (JNJ) has quietly ground higher, with the stock up roughly 7% over the past month and nearly 14% in the past 3 months, drawing fresh attention from income focused investors. See our latest analysis for Johnson & Johnson. Zooming out, that steady climb sits on top of a powerful backdrop, with a roughly 39% year to date share price return and a three year total shareholder return above 22% suggesting momentum is still firmly building as investors reassess Johnson & Johnson’s...",
        "pubDate": "2025-12-10T00:11:27Z",
        "displayTime": "2025-12-10T00:11:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T12:31:00+00:00",
    "headline": "JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?",
    "summary": "JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.",
    "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8b59f587-2747-3b59-8772-5695fe2d24b7",
      "content": {
        "id": "8b59f587-2747-3b59-8772-5695fe2d24b7",
        "contentType": "STORY",
        "title": "JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?",
        "description": "",
        "summary": "JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.",
        "pubDate": "2025-12-10T12:31:00Z",
        "displayTime": "2025-12-10T12:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2fLjSeGpHAp4pnNFR6egw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qPY9mhd4gwuyP0ATgGKKxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]